Probiotics China News Bites – April 2025
Recently, Sirio Pharma stated on the Shenzhen Stock Exchange interactive platform that exports from its China-based production to the U.S. account for less than 15% of its total revenue. The company is actively adopting multiple strategies to control the impact of “reciprocal tariffs” on its U.S. export business. Sirio promptly initiated discussions with clients to … Read more